These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15225090)

  • 21. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
    Ianov IuK; Novik AA; Belokhvostov AS
    Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
    [No Abstract]   [Full Text] [Related]  

  • 22. Interpretation of treatment results with biological agents: is there a need for a new methodology?
    Begent RH
    J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular diagnosis and therapy in oncology].
    Baretton G; Grabbe S; Keilholz U; Sauter G
    Onkologie; 2011; 34 Suppl 2():5-9. PubMed ID: 21447986
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular cancer diagnostics.
    Marte B; Eccleston A; Nath D
    Nature; 2008 Apr; 452(7187):547. PubMed ID: 18385727
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteomics in the forefront of cancer biomarker discovery.
    Srivastava S; Srivastava RG
    J Proteome Res; 2005; 4(4):1098-103. PubMed ID: 16083258
    [No Abstract]   [Full Text] [Related]  

  • 27. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 28. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics. Updates on cancer drugs.
    Kibble A
    IDrugs; 2007 Jan; 10(1):3-4. PubMed ID: 17187302
    [No Abstract]   [Full Text] [Related]  

  • 29. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A; Schilsky RL; Nevins JR
    Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis for therapy choice: NCI MATCH.
    Conley BA; Doroshow JH
    Semin Oncol; 2014 Jun; 41(3):297-9. PubMed ID: 25023344
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostics in cancer drug development.
    Sikora K
    Expert Rev Mol Diagn; 2004 Mar; 4(2):127-9. PubMed ID: 14995899
    [No Abstract]   [Full Text] [Related]  

  • 32. A target or a demi-target.
    Mok TS
    Clin Lung Cancer; 2010 May; 11(3):147-8. PubMed ID: 20439189
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 34. Intracellular signal transduction pathway proteins as targets for cancer therapy.
    Adjei AA; Hidalgo M
    J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research.
    Barrett JC; Bennett LM; Fleming LK; Linehan WM; Liotta LA; Rosenberg SA; Petricoin EF; Staudt LM; Thompson TE; Yang JC
    Clin Adv Hematol Oncol; 2003 May; 1(5):302-6. PubMed ID: 16224427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular imaging in cancer.
    Weissleder R
    Science; 2006 May; 312(5777):1168-71. PubMed ID: 16728630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspectives of epothilones in breast cancer.
    Cardoso F; de Azambuja E; Lago LD
    Eur J Cancer; 2008 Feb; 44(3):341-52. PubMed ID: 18178426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial carboxyhemoglobin concentrations as a predictor of chemosensitivity in elderly patients with advanced lung cancer.
    Yasuda H; Yamaya M; Nakayama K; Ebihara S; Asada M; Sasaki T; Inoue D; Yoshida M; Kubo H; Sasaki H
    J Am Geriatr Soc; 2006 Feb; 54(2):373-5. PubMed ID: 16460400
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical biomarkers of kinase activity: examples from EGFR inhibition trials.
    Krause M; Baumann M
    Cancer Metastasis Rev; 2008 Sep; 27(3):387-402. PubMed ID: 18427731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.